Does RUXOLITINIB Cause Red cell distribution width increased? 105 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 105 reports of Red cell distribution width increased have been filed in association with RUXOLITINIB (OPZELURA). This represents 0.2% of all adverse event reports for RUXOLITINIB.
105
Reports of Red cell distribution width increased with RUXOLITINIB
0.2%
of all RUXOLITINIB reports
18
Deaths
45
Hospitalizations
How Dangerous Is Red cell distribution width increased From RUXOLITINIB?
Of the 105 reports, 18 (17.1%) resulted in death, 45 (42.9%) required hospitalization, and 3 (2.9%) were considered life-threatening.
Is Red cell distribution width increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RUXOLITINIB. However, 105 reports have been filed with the FAERS database.
What Other Side Effects Does RUXOLITINIB Cause?
Off label use (12,492)
Death (6,561)
Fatigue (5,663)
Anaemia (3,593)
Haemoglobin decreased (3,297)
Platelet count decreased (3,028)
Diarrhoea (2,531)
Asthenia (2,529)
Dizziness (2,398)
Pneumonia (2,343)
What Other Drugs Cause Red cell distribution width increased?
CLOZAPINE (439)
METHOTREXATE (210)
ALEMTUZUMAB (202)
RITUXIMAB (198)
PREDNISONE (178)
PALBOCICLIB (171)
ADALIMUMAB (144)
METHYLPREDNISOLONE (123)
ECULIZUMAB (110)
TOCILIZUMAB (108)
Which RUXOLITINIB Alternatives Have Lower Red cell distribution width increased Risk?
RUXOLITINIB vs SABRIL
RUXOLITINIB vs SACCHAROMYCES CEREVISIAE
RUXOLITINIB vs SACITUZUMAB GOVITECAN
RUXOLITINIB vs SACITUZUMAB GOVITECAN-HZIY
RUXOLITINIB vs SACROSIDASE